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The high prevalence of alcohol use disorder continues to impact individuals by heightening 
stress, anxiety and disrupting cognitive tasks (Morrow and Creese, 1986). Ethanol affects 
several neuromodulator systems, exerting its effects within the central nervous system (Deehan 
et al., 2013). One known effect of ethanol is its impact on the mesocorticolimbic system and 
related circuits, including the ventral tegmental area and its involvement in the regulation of 
motivation and goal-directed behavior (Doyon et al., 2020). The neurotransmitter 
norepinephrine has also been linked to mood stabilization, alertness, as well as the endocrine 
and autonomic nervous systems (Vazey et al., 2018). Additional issues remain to be explored, 
such as the interaction between norepinephrine signaling and other neuromodulators, and a 
better mechanistic understanding of ethanol withdrawal (Kushner et al., 2000; Skelly and 
Weiner 2014; Fredriksson et al., 2015; Becker and Koob, 2016; Petrakis et al., 2016). In order 
to increase our understanding of alcohol use disorder I carried out two experiments throughout 
the course of my thesis. We conducted an ethanol vapor study showing that we were able to 
successfully induce alcohol dependence and withdrawal through a short ten-day vapor 
exposure model in Long Evans male rats. Lastly, we created a time course of ethanol in the 
ventral tegmental area through gas chromatography analysis, also using microdialysis. In the 
appendix we also show pilot data from a study were we closely examined the estrous cycle in 
 vii 
female rats that underwent surgery to place an intracranial guide cannula for microdialysis 
experiments. We found the possible surgical effects that can halt cycling and ultimately affect 
data looking at differences between males and females in alcohol dependance and withdrawal, 
however more experiments are necessary to make a precise conclusion. Findings from these 
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Alcohol Use Disorder 
Alcohol Use Disorder (AUD) is defined as a chronic relapsing brain disease 
characterized by compulsive alcohol use, loss of control over alcohol intake, and a negative 
emotional state when not using (NIAAA, 2021). Within the United States 15.8 million adults 
over the age of eighteen suffer from this disease (6.2 percent), resulting in only a startling 6 
percent of those with the disorder seeking some sort of treatment in their lifetime (NIAAA, 
2021). AUD is a multi-faceted disease that not only affects the individual but also has familial, 
social and global impacts. In 2010 alone, alcohol misuse costs the United States $249.0 billion 
dollars and has been globally ranked as the fifth leading risk factor for premature death and 
disability among adults (NIAAA, 2021). 
In the United States specifically, we see a multitude of dangerous drinking behaviors 
starting from ages as young as twelve, which are than carried out through high school, college 
and onto adulthood. Binge drinking, the consumption of four drinks or more in two hours in 
females (five or more drinks in males), is particularly growing in popularity among a variety 
of age groups (Becker and Koob, 2016). This dangerous behavior is known to increase an 
individuals’ chance of developing an AUD and ultimately contributes to the growing epidemic 
in the United States. 
Individuals with AUD can suffer from a disruption of a number of brain functions 
including motivation, emotion, and cognition. Alcohol dependence will not only produce an 
elevated motivation for seeking alcohol but will also negatively impact an individual by 
heightening stress, anxiety and disrupt cognitive tasks such as decision making (Vazey et al., 
2018). The high prevalence of AUD, alongside the wide range of effects of ethanol on 




research. Research over the years has aimed to better understand site-specific actions of ethanol 
on a number of brain regions with the goal to create a treatment that can alleviate the multitude 
of symptoms that come along with AUD. 
Norepinephrine  
Norepinephrine is a central nervous system (CNS) neurotransmitter that plays a role in 
a wide variety of effects on animal and human physiology. The largest populations of 
noradrenergic neurons are found in the bilateral locus coeruleus (LC) and subcoeruleus found 
in the dorsal pons. Aside from downward projections to the brainstem and spinal cord the LC 
provides an array of projections to the cerebral cortex, hippocampus, amygdala, dorsal BNST 
and some parts of the hypothalamus. Another important cluster of noradrenergic neurons can 
be found in the nucleus tractus solitarius (NTS), which in turn project to homeostatic and limbic 
regions of the forebrain (Vazey et al., 2018). This extensive projection pattern throughout the 
brain sets the groundwork for the global effects that norepinephrine as a regulator of critical 
homeostatic, emotional and cognitive functions. 
In the central nervous system norepinephrine, as stated above, has a vast number of 
projections throughout the entire brain. As such an important chemical messenger with a global 
reach norepinephrine plays a profound role in a wide range of behaviors and functions. 
Norepinephrine has been directly linked to mood stabilization, sleep regulation, aspects of 
cognition, motivation, and alertness and arousal. In addition, norepinephrine influences the 
function of  the endocrine and autonomic nervous systems (Vazey et al. 2018). 
The Role of Norepinephrine in Ethanol Reward 
Noradrenergic transmission was found to be a crucial mechanism in the rewarding 
effects of different classes of drugs of abuse, such as psychostimulants and opioids. In 




salience to stimuli associated with drugs (Ventura et al. 2008). Such results could indicate that 
norepinephrine transmission in the prefrontal cortex is a neural substrate that may also be 
crucial in the rewarding effects of other drugs such as ethanol. 
 In the early 2000’s, studies began to emerge that reinforced the idea that 
norepinephrine contributes to ethanol reward. Weinshenker et al. (2000) showed that dopamine 
beta hydroxylase knockout mice demonstrate a reduced voluntary ethanol consumption, stating 
that even though this reduction may result from a deficit in ethanol reward, it can also be due 
to an increased sensitivity to ethanol’s aversive effects in the mice. Another study showed that 
reducing norepinephrine transmission via activation of the  autoreceptor decreased alcohol 
self-administration, whereas increasing norepinephrine via the blockade of this receptor 
enhanced alcohol self-administration (Le et al., 2005). Lastly, Ventura et al. (2006) has 
conducted a multitude of experiments examining norepinephrine in relation to the conditioning 
effects of ethanol, concluding that norepinephrine in the medial prefrontal cortex is necessary 
to produce ethanol-induced conditioned place preference and for voluntary consumption.  
In early human studies, acute ethanol exposure was found to increase norepinephrine 
and the norepinephrine metabolite 3-methoxy-4-hydroxy-phenylglycol (MHPG) measured in 
cerebral spinal fluid (CSF) and plasma. The increase in norepinephrine was found to be greater 
in alcoholic patients than in healthy controls and was connected to blood alcohol levels. The 
increased levels observed in patients decreased significantly after multiple days of abstinence 
(Borg et al. 1981; Howes and Reid, 1985).  
The Role of Norepinephrine in the Physical Dependence of Ethanol 
In alcohol dependent animals receiving daily ethanol gavage, norepinephrine 
metabolite levels remained high, both while the animals were intoxicated and while they 




al., 1976). Repeated alcohol administration has also been known to sensitize norepinephrine 
neurons to release larger amounts of norepinephrine (Lanteri et al., 2008). Chronic alcohol 
exposure was also found to induce c-Fos expression in the nucleus tractus solitarius in males 
and females (Ryabinin et al., 1997). Additionally, c-Fos signaling was shown to increase in the 
locus coeruleus of females but not males, potentially indicating some region-specific 
adaptations in norepinephrine signaling (Retson et al., 2015; Vazey et al., 2018). However, 
withdrawal from chronic alcohol universally activates norepinephrine signaling across regions 
(Vilpoux et al., 2009). 
Alcohol withdrawal is associated with negative symptoms and is thought to be a main 
contributor as to why individuals continue to seek out alcohol. There are multiple hypotheses 
such as that alcohol dependence causes noradrenergic adaptions in the prefrontal cortex that 
lead to an increase in release of extracellular norepinephrine and an increase in tissue content 
of norepinephrine during ethanol withdrawal (Vena et al., 2020). Testing these hypotheses 
about ethanol withdrawal led us to characterize an alcohol dependence model using ethanol 
vapor. This could lead to examination of a possible time course of withdrawal that could be 
useful in furthering treatment. 
Treatment 
Noradrenergic targets have been a big interest among researchers because drugs may 
be developed to activate or inhibit such targets as a possible treatment for alcohol use disorder. 
Additional issues remain to be explored, such as the interaction between norepinephrine 
signaling and other neuromodulators, sex differences in norepinephrine function and better 
understanding of norepinephrine during withdrawal (Kushner et al., 2000; Skelly and Weiner 




In the periphery, alpha-1 adrenergic receptors are G-protein coupled receptors that are 
localized postsynaptically in smooth muscle adjacent to nerve terminals and mediate artery and 
vein vasoconstriction. In the central nervous system activation of this receptor decreases 
cellular excitability in the temporal cortex and decreases glutamatergic excitatory postsynaptic 
potential (Haass-Koffler et al. 2018). Several selective alpha-1 adrenergic receptor blockers 
have already been FDA approved for hypertension and hyperplasia (Eskinder et al. 1989). This 
has provided an opportunity for researchers to have the ready availability of these medications, 
such as prazosin and doxazosin, to be tested on animal and human models for alcohol use 
disorder. The alpha-1 receptor antagonist prazosin is active in the central nervous system and 
can easily cross the blood-brain barrier, while doxazosin is less penetrable but still holds central 
nervous system effects  (Michel et al. 1989). Prazosin was found to reduce alcohol dependence-
induced operant responding during withdrawal but not in the non-dependent rats (Walker et al. 
2008). Additionally, studies supported the role of prazosin as a treatment for alcohol use 
disorder by showing that, in rats selectively bred for alcohol preference, prazosin suppressed 
alcohol drinking using a two-bottle choice paradigm (Haass-Koffler et al. 2018; Rasmussen et 
al. 2009). Prazosin in clinical studies has been tested in individuals that have been affected by 
alcohol use disorder. In a study where prazosin was tested during a six-week pilot randomized 
clinical trial in individuals seeking treatment for alcohol use disorder (N=24) the prazosin 
group compared to the placebo group reported fewer drinking days per week and fewer drinks 
per week. (Haass-Koffler et al. 2018; Simpson et al. 2009). 
The alpha-2 adrenergic receptors are G-protein coupled receptors expressed in the 
central nervous system resulting in sympatholytic effects when stimulated, such as hypnosis, 
analgesia, and sedation. These responses are thought to be due to the hyperpolarization of 




Presynaptically the alpha-2 adrenergic receptors also act as autoreceptors acting through a 
negative feedback mechanism. Clonidine, originally intended as a medication for hypertension, 
is the oldest FDA approved agonist for the alpha -2 adrenergic receptor. This drug has also 
been hypothesized to be a potential treatment for alcohol withdrawal for a few decades. 
Clonidine can cross the blood-brain barrier and acts as an agonist on  alpha-2 adrenergic 
receptors located in the brainstem (Haass-Koffler et al. 2018). Once clonidine passes the blood-
brain barrier it is able to decrease norepinephrine release from presynaptic terminals and 
postsynaptically decreases sympathetic conduction, resulting in lower noradrenergic signaling. 
In human trials clonidine is known to reduce sedation after a period of heavy alcohol intake, 
and has also shown to improve the alcohol withdrawal symptoms (Mirijello et al. 2015). 
Propranolol, a medication acting on postsynaptic beta-1 and beta-2 adrenergic 
receptors, has also shown some promising data when treating alcohol use disorder. In a 
preclinical study where rats were alcohol-dependent through chronic intermittent alcohol vapor 
inhalation (14 h ON/10 h OFF) and then trained to respond for alcohol in an operant 
conditioning paradigm on a progressive ratio reinforcement schedule, propranolol was able to 
decrease alcohol withdrawal induced operant responding for alcohol (Gilpin and Koob, 2010). 
It has also been found that the combination of prazosin with propranolol reduced alcohol 
consumption during both alcohol withdrawal and better promoted prolonged abstinence. The 
combination of these two medications was more effective than single drug treatment in alcohol 
preferring rats, when given a 2-h free choice between alcohol and water (Rasmussen et al., 
2014). 
Sex Differences 
As of recently sex difference research has gained speed across a wide range of 




multitude of concepts; quantitative differences are characterized as the differences in which 
males and females differ in the magnitude of their response. The trait is the same, but one sex 
exhibits a greater response than the other. This can be seen in many dose response studies 
showing that female rats display a greater locomotor response to psychomotor stimulants and 
more behavioral sensitization than do males (Becker and Koob, 2016). Sex differences in 
neural mechanisms that mediate behaviors is also possible. Both males and females exhibit a 
corticotropin-releasing factor-1 (CRF1) receptor response to stimulation with CRF, but there 
is a difference in the intracellular signaling pathways between males and females (Bangasser 
and Valentino, 2014). Furthermore, there may also be effects of the estrous cycle and 
influences of gonadal hormones on neural mechanisms that mediate behavior (Becker and 
Koob, 2016).  
Traditionally data has shown that men drink larger amounts of alcohol compared to 
women, but recent data has been indicating that the consumption rate for men and women is 
becoming more similar and has been for the last several decades (Keyes et al. 2008). 
Differences are especially being seen in the drinking patterns between women and men, more 
specifically men have more drinking days per month than women. In addition binging episodes 
have increased overall for females and decreased for males. Both social factors and biological 
mechanisms have been argued to contribute to sex differences in alcohol drinking patterns, 
suggesting that women who become addicted progress through initial use to dependence at a 
faster rate than men (Becker and Koob, 2016). In studies examining alcohol consumption in 
rats using the two-bottle choice paradigm to examine preference for alcohol over a 24-hour 
period, female rats of various strains showed greater alcohol intake and preference in two-




studies also showed that females did not decrease intake as much as males when the alcohol 
concentration was increased (Meliska et al., 1995). 
Estrous Cycling 
Preclinical studies indicate that gonadal hormones are important factors that regulate 
drug self-administration in female animals as well as human females. Studies involving human 
participants have reported increased subjective ratings of euphoria and craving during the 
follicular phase (high estrogen) compared to the luteal phase (moderate estrogen) following 
administration of amphetamine and smoked cocaine (Evans and Foltin, 2006). Similarly, 
studies conducted in rats reveal that drug sensitivity and drug self-administration are dependent 
on gonadal sex hormones and vary across the rat estrous cycle (Lacy et al., 2016; Caine et al., 
2004). Stress, including the stress due to invasive surgical procedures, has been known to affect 
estrous cycling and could potentially add unwanted confounding variables if proper steps are 
not taken (Silva et al., 2020). Continuing the involvement of females in future experiments is 
important for the advancement of the addiction field, however we must be aware of different 
components that can affect the estrous cycle and ultimately the interpretation of our data. See 
the appendix for pilot data on how invasive surgical procedure may influence estrous cycling. 
Pharmacokinetics 
To understand the mechanisms that underlie ethanol-related behavior requires a 
combination of behavioral analysis along with in vivo measurements of cellular or chemical 
activity in the brain.  Microdialysis has been used in the neuroscience and neuropharmacology 
fields to monitor neurochemical activity in conscious, freely moving animals.  Microdialysis 
is a technique, in which a semipermeable membrane is implanted into a specific brain region 




There are several ways that microdialysis is useful in alcohol research. For example, 
microdialysis has been used to examine whether acute ethanol stimulates both the locus 
coeruleus and the nucleus tractus solitarius noradrenergic neurons (Jaime et al., 2020).  
Additionally, limited ethanol self-administration experience alters dialysate norepinephrine in 
the medial prefrontal cortex in a manner consistent with a decrease in tonic norepinephrine 
release (Jaime et al., 2020). Other experiments used acute intravenous administration of ethanol 
(1 g/kg) and microdialysis to show an increase of 77% norepinephrine above baseline in the 
medial prefrontal cortex when compared to controls. Together these studies suggest that 
ethanol’s effects on norepinephrine in brain are related to a stress response rather than the 
rewarding properties of ethanol (Jaime et al., 2017). 
A major theoretical issue while using microdialysis as a technique has been how to 
calibrate probes to allow prediction of brain concentrations of an analyte from dialysate 
concentrations.  Throughout the field however, it is widely understood that using in vitro 
calibrations for in vivo measurements is not valid (Gonzales et al., 2002). Although there are 
difficulties, several quantitative methods are used to gain some insight into mechanisms of 
actions of ethanol in the brain. One method that has been used is to conduct separate 
experiments in another group of rats to determine an in vivo extraction fraction for ethanol 
(Robinson et al., 2000).  The in vivo extraction fraction for ethanol can be calculated by 
computing the ratio of the dialysate ethanol concentration to the blood ethanol concentration. 
Using this method, the time course for the tissue change in ethanol concentration can be 
estimated. This method allows us to estimate tissue concentrations after various ethanol doses 
with the use of a minimal number of animals, unlike ethanol analysis from tissue extractions 





Chapter 1: Ten Day Ethanol Vapor Exposure Model 
 
Dependence is defined by the physical adaptations that occur with repeated exposures 
to drugs, while “physical dependence” is most often associated with the presence of withdrawal 
symptoms and the development of tolerance (Funk et al., 2006). Ethanol vapor exposure has 
been a preferred method of inducing dependence in rodents in several studies (Funk et al., 
2006). It is a non-invasive procedure that allows precise control over the dose, duration, and 
pattern of exposure. Several studies have used chronic intermittent ethanol (CIE) exposure, in 
which the animals undergo cycles of alcohol exposure and alcohol abstinence lasting from 
weeks to months. This procedure has been used to increase self-administration drinking in pre-
exposed rats after only 2 weeks of alcohol vapor exposure (O'Dell et al., 2004; Gilpin et al., 
2009). In studies where the animals have had no pre-exposure to alcohol, ethanol vapor 
exposure was used to produce increases in the initiation and maintenance of alcohol self-
administration following  seven weeks of ethanol exposure (Rimondini et al., 2003; Gilpin et 
al., 2009). 
 While the ethanol vapor exposure model has been well known in the field for some 
time, it has widely been used as a long-term procedure ranging anywhere between four to eight 
weeks in naïve rodents. With the extended time, previous investigators typically started with 
low ethanol exposure rates, and the rates were steadily increased to maintain a blood alcohol 
concentration (BAC) of 0.15 g/dl (Gilpin et al., 2009; Funk et al., 2007). In these longer 
exposure periods, withdrawal was also documented and was observed for at least 48 hours after 
exposure (Gilpin et al., 2009). However, it is not known if this extended exposure is necessary 




dependence development in naïve rats, except in adolescent rats (Healey et al., 2020). Our 
studies use the same BAC, as well as withdrawal and intoxication criteria used in long term 
ethanol exposure studies, but instead we aim to examine if alcohol dependence can be 
successfully induced in a shorter ten-day exposure model in adult male rodents. 
Methodology 
Species 
Long Evans male rats were used in all vapor experiments. Rats were ordered at a 
weight range of 300.0 -325.0 g (Envigo, Alice, TX). Once the rats were received, each rat 
was handled for at least ten minutes daily for a week by everyone involved in the experiment. 
Handling consisted of mimicking movements each rat would experience during intoxication 
and withdrawal scoring. 
Vapor Chambers 
Acrylic chambers measuring 2’x2’x2’ (¼ in. thickness) were designed by the Becker 
Lab (Becker and Lopez, 2004) and manufactured by a local company (Regal Plastics, Austin, 
TX). Two standard rat cages (17 in. X 8½ in. X 8 in.) were placed in each chamber, in which 
rodents were single-housed during exposure. Each chamber was connected to two pumps 
(ethanol: Matala, HK-40L; air: Matala, HK-25L); one to pump fresh air continuously into each 
chamber, while a second was used to pump alcohol vapor. Ethanol exposure consisted of a 14 
hours on/10 hours off model for ten consecutive days (Gilpin et al., 2009). Fresh air and ethanol 
vapor are pumped at variable rates at a combined 10 L/min, with air continuously being 




The ethanol pump was connected by tubing (USP Item #: 54033, 1/4" ID x 3/8" OD 
Silicone® Tubing) to a y-connector and two on/off valves. One valve was connected to an 
ethanol bottle (Pharmaco, Ethyl Alcohol 200 Proof, Absolute, Anhydrous ACS/USP Grade) 
containing three carbonating stones (carbonating stone with 1/4" barb, 2-micron pore size) that 
generated ethanol vapor when turned on. Vapor from the ethanol bottle was then routed by a 
one-way valve to a flowmeter (Cole Parmer, PMR1-016598). The flowmeter allowed control 
of the rates of ethanol that were delivered to the animals. From the flowmeter, the ethanol vapor 
then flowed through a one-way valve to a y-connector and into the designated ethanol chamber 
(Illustration 1). 
 




The air pump is connected by tubing (USP Item #: 54033, 1/4" ID x 3/8" OD Silicone® 
Tubing) directly to a flowmeter (Cole Parmer, FR4A41BVBN-CP). This maintained a 
combined exposure of 10 L/min while the ethanol flowrates varied. From the flowmeter, the 
air then flowed through more tubing to a y-connector connected to the designated chamber. 
Vapor Standards 
Vapor standards were made by injecting known quantities of ethanol (Pharmaco, 95% 
Ethyl Alcohol, Absolute, Anhydrous ACS/USP Grade) into calibrated 1 liter glass bottles with 
silicone/PTFE septa caps. The aliquots (25 uL, 50 uL, and 75 uL) were injected into three 
separate glass bottles using a gastight microsyringe (Hamilton, 1725TLL). Ethanol vaporized 
inside the bottle for thirty minutes at room temperature. A 25 ul microsyringe (syringe: 
Hamilton, 1725TLL 250ul SYR; needle: Hamilton, RN NDL (22s/2 “/2) S LOT# 647808) was 
used to sample 15 uL of air from the glass bottles through the septa, and then slowly injected 
into a 2 ml GC sample vial (septum cap: Agilent, Part# 5182-0722) through the septum. The 
ethanol in the vapor chambers was sampled in a similar way through the chamber port. 
A Bruker 456-GC gas chromatograph with a flame ionization detector and a Varian 
8400 autosampler were used to quantify ethanol in vapor and vapor standards, as well as blood 
and blood standards. Gas chromatography analysis methods can be found in Jaime et al. (2020).  
Blood Sampling 
Animals were removed from the vapor chambers individually and placed under 
anesthesia (isoflurane). One back leg of each rat was then shaved to expose the saphenous vein. 




which 10 uL of blood were collected with a pipette into a 2 ml GC vial prefilled with 90 uL of 
saturated saline. All blood samples were taken in triplicates. External standards were made 
using 10 uL of known ethanol concentrations (40 mM, 20 mM, 10 mM, 5 mM) pipetted into 
GC vials with 90 uL of saturated saline.  
Intoxication Scoring 
Once the chambers were turned off, each rat was evaluated for severity of intoxication 
for that exposure day. Long Evans rats were placed on a flat surface that gave them plenty of 
room to move around and were observed for no longer than a minute. Long Evans rats were 
then evaluated and scored using an intoxication scale ranging from 1 (normal) to 6 (anesthetic 
dose) (see Table 1). If a Long Evans rat scored an intoxication score of 5 (loss of righting reflex 
greater than 30 seconds) a DuraSorb non-sterile underpad (Fisher, NC9325160) was placed 
over the bedding and a 1 ml injection of saline was given to promote hydration. The rat was 
monitored, and the surgery pad removed once the rat gained mobility.  
 




Score Behavioral Description                 
1 Normal 
2 Stumbling, no swimming or loss of righting reflex 
3 Swimming 
4 Loss of righting reflex (greater than 2 seconds, less than 30 seconds) 
5 Loss of righting reflex (greater than 30 seconds) 





On the last day of ethanol vapor exposure, each rat was observed for behavioral signs 
of ethanol withdrawal at four and eight hours after the chamber was turned off. During 
observation, each Long Evans rat was placed into a clean home cage and videotaped while live 
scoring was conducted. Our alcohol withdrawal assessment consisted of observing the 
following behaviors: posture/gait, tail stiffness, ventromedial distal limb flexion and 
irritability. Each behavior was scored on a scale from 0 to 2, 0 being normal behavior and 2 




















The flow rate for day one during each vapor exposure cohort was set at a starting 
ethanol vapor flow rate of 3.2 L/min. This flow was relatively low because the first day was 
Behavior 
Withdrawal Scoring 
0 1 2 
Posture/ Gait Normal posture/gait 
Slight stiffness in 





and hunched posture 
such that rat has 
difficulty walking 








Slight but consistent 
elevation of tail 
above bedding as 
animal walks, slight 
curling of tip of tail 
upward 
 







One limb flexed or 
partial flexion in 
either or both of 
limbs 
 
Complete flexion of 
both limbs 
Irritability 
Docile to all 
handling 
Docile to touch, 
when grasped 
wiggles and makes 
vocalization 
 
Reacts to touch and 
grasping with 
vocalization, biting, 





used to habituate the animals to the vapor chambers. On subsequent days the ethanol flow was 
increased and adjusted each day based on the intoxication score and BAL. During these nine 
days the chamber vapor concentration averaged at about 35.3 mg/L, consistent with previous 
vapor samples analyzed by gas chromatography. It is common for the flow rates to increase 
and decrease throughout the duration of the experiment- for example, day two averaged at a 
vapor concentration of 43.26 mg/L while day three averaged at 38.18 mg/L. Technical 
difficulties with the GC were experienced during both experimental cohorts, which resulted in 
collecting vapor samples only up to day eight for the first cohort, and day six for the second.  
Intoxication scoring was conducted each day after the chambers were turned off (see 
methodology for intoxication scoring table). Figure 1 shows the average (n=10) intoxication 
score over the course of the ten-day vapor exposure model.  Intoxication was modest 
throughout exposure in which most of the rats showed signs of staggering. However, a few of 
our Long Evans rats did experience severe intoxication resulting in a loss of righting reflex. A 
repeated measures one-way ANOVA was conducted and showed that there was a difference in 
intoxication scores throughout the ten days of vapor exposure (F (9,81) = 2.518, p < 0.05). Post 
hoc analysis showed that the severity of intoxication on day four was significantly different 
than the first three days of exposure (F (3,81) = 4.401, p < 0.05).  While these analyses showed 




induce measurable intoxication throughout the exposure period, even though it is well known 
that tolerance is being developed.  
 
 
Aside from daily intoxication scoring to assess vapor intoxication, we also took blood 
alcohol concentration samples three times throughout the ten-day vapor exposure to be 
analyzed by the GC. The target BAC we used to induce dependence was 0.15 g/dl. Figure 2 
shows the average BAC from the three collections during the ten-day vapor exposure (n=8). 
The graph shows that the target range of 0.15 g/dl was surpassed on each collection day.  
Figure 1. Daily Intoxication Scores. The following graph shows the average intoxication 
score over the course of a ten-day vapor exposure model. Long Evans rats exposed to 





Withdrawal Assessment   
To verify that we successfully induced alcohol dependence with this ten-day vapor 
exposure model, we assessed withdrawal symptoms in each ethanol and air exposed Long 
Evans rat.  Figure 3 shows the weights of both ethanol (n=8) and air (n=7) exposed animals at 
pre-exposure and on day 9 of exposure. Notably, while air-exposed animals continued to gain 
weight throughout the duration of the ten-day exposure, ethanol-exposed rats lost weight. The 
difference between the ethanol and air exposed rats was substantiated by a one-way ANOVA 
Figure 2: Blood Alcohol Concentrations. BACs are collected three times throughout 
exposure to maintain a minimum BAC of 0.15 g/dl throughout the ten days of ethanol vapor 
exposure (n =8). We have been successful in maintaining a minimum BAC to induce 







in which a significant interaction was detected (F (1,13) = 8.23. p < 0.05). Further investigation 
was needed to explore the   interaction of exposure day and vapor. A post hoc one-way 
ANOVA was conducted on day nine weights, which showed that there is a significant effect 




On day ten of our exposure model, both vapor and air exposed Long Evans rats 
underwent a withdrawal assessment at four and eight hours after the chambers were turned off 
Figure 3: Weight Throughout Ethanol Exposure. Weight in grams in both ethanol and air 
group pre-exposure and towards the end of exposure (n= 8-9). The ethanol group lost 
weight throughout exposure, while the air group gained weight (error bars represent the 






(see methodology for withdrawal assessment table). Animals were scored on four behaviors to 
assess the severity of withdrawal (irritability, ventromedial distal limb flexion, posture/gait, 
and tail stiffness). Figure 4 shows that ethanol exposed animals (n=8) showed signs of 
withdrawal at both four and eight hours after exposure. Air exposed animals (n=7) were also 
assessed but did not show signs of withdrawal at any time point.  
 
 
Figure 4: Ethanol Withdrawal Behavior. On day ten of exposure all Long Evans rats 
underwent a withdrawal assessment to determine if ten days of vapor exposure was 
successful in inducing alcohol dependence. The following graph shows that ethanol 
exposed rats (n=8) showed behavioral signs of withdrawal at 4hrs and 8hrs after the last 
exposure. (error bars represent the standard error of the mean). Air exposed animals are not 









 The data collected from our ethanol vapor study showed that we were able to 
successfully induce alcohol dependence and withdrawal through a short ten-day vapor 
exposure. We were able to maintain all ethanol exposed Long Evans rats throughout the ten 
days at target BACs of at least 0.15 g/dl. Additionally, ethanol exposed rats showed signs of 
moderate withdrawal at four and eight hours after the chambers were turned off, with no signs 
of seizures. It is also important to consider individual differences in each animal that could 
potentially affect how severely intoxicated they become during each exposure. For example, 
severe intoxication could ultimately lead to weight loss during the experiment. One possibility 
to determine the effects of weight loss could be adding a pair feeding group to future 
experiments.   
 Previous models for inducing physical alcohol dependence have reported withdrawal 
behaviors in rodents up to twenty-four hours after there last exposure. For example, 
Majchrowicz (1975) was one of the first to report observing withdrawal behaviors up to sixteen 
hours after a high dose gavage model. On the other hand, Gilpin (2009) used a four-week vapor 
exposure model and stated that all physical signs of withdrawal in rodents subsided after 
twenty-four hours from the chambers being turned off. As stated above, our ten-day ethanol 
vapor exposure model was successful in inducing moderate withdrawal at four and eight hours 
after chambers were turned off. By using a shorter ethanol vapor exposure model, we expected 
our ethanol exposed animals to be on the lower end of expressing withdrawal behavior. With 
this in mind, we did not continue to observe the ethanol exposed rats for withdrawal behavior 




 Using a short ethanol vapor exposure model could be useful in determining cellular 
and molecular mechanisms in early stages of dependence. For example, it is not known if 
norepinephrine release is affected during withdrawal. Alcohol withdrawal is associated with 
negative symptoms and is thought to be a main contributor to the continuation of alcohol-
seeking by individuals. Alcohol dependence could potentially cause noradrenergic adaptations 
that affect the release of extracellular norepinephrine. Future experiments utilizing a short 
vapor exposure model and microdialysis could potentially explore these possible adaptations 
caused by ethanol. Funk et al. (2007) used a longer vapor exposure model of four weeks to 
show that ethanol-dependent animals display enhanced anxiety-like behaviors and enhanced 
ethanol self-administration during withdrawal, resulting from a dysregulation of corticotropin-
releasing factor (CRF) stress systems. Future studies could use a shorter vapor exposure model 
to determine if adaptations in the CRF stress systems are affected during shorter periods of 
exposure. Exploring the mechanisms of early CRF and norepinephrine adaptations could lead 
to a better understanding of the beginning stages of addiction. 
 Through the duration of the vapor experiment we noticed that ethanol vapor exposed 
animals lost weight when compared to air exposed Long Evans rats. Gilpin et al. (2009) used 
a BAC target range of 0.15 g/dl to 0.225 g/dl to limit severe exposure in animals. The authors 
further mentioned that animals that are unresponsive at the end of exposure often lose a 
significant amount of body weight. In addition, they suggested general observational guidelines 
to help prevent severe intoxication should be considered on days that BACs are not collected 
as follows: 




• .30 to .40 g/dl (or higher) BAC: rat is totally unresponsive 
 If the intoxication signs reach these levels vapor concentration levels should be 
adjusted accordingly. Analysis of the weight data in our study also leads to the conclusion that 
care should be taken to avoid potential overexposure. This can be done by taking weights 
before vapor exposure begins and following the weight of the animal on a daily basis during 
the experiment. Weight loss throughout exposure should be considered a sign of consistent 
severe intoxication.  
 In the published literature, Trantham-Davidson et al. (2017) used a two day vapor 
exposure model that was repeated for four cycles in adolescent rats. In this study the adolescent 
rats were exposed to vapor for a total of eight days, however each exposure period was 
followed by a period of abstinence. Furthermore, the investigator documented significant 
intoxication during each exposure day, however they did not report any evidence of withdrawal 
signs after the fourth cycle. In addition, Gass et al. 2017 used a two week ethanol vapor 
exposure model in adult rats, but they also did not report whether signs of physical dependance 
had developed after the vapor was turned off.  Our vapor study, however, is currently the 
shortest vapor exposure model that has been able to successfully induce alcohol dependence 
over ten days in adult rats. Throughout our study, all ethanol exposed Long Evans rats-
maintained intoxication and showed signs of withdrawal at four and eight hours after the 
chambers were turned off. Our short-term exposure model could be used to investigate the 





Chapter 2: Time course of Ethanol in the Ventral Tegmental Area 
 Alcohol use disorder and dependence are believed to be influenced by alcohol's 
pharmacological effects on the mesocorticolimbic system (Dehaan et al., 2013). As part of the 
mesocorticolimbic system the ventral tegmental area (VTA) is involved in the regulation of 
motivation and goal-directed behavior (Doyon et al., 2020).  It is known that VTA neurons 
mainly synthesize dopamine, GABA, and glutamate (Nair-Roberts et al., 2008). A number of 
studies have examined these neurons in animals under anesthesia, finding that the 
administration of ethanol induces a moderate dose-dependent increase in the firing rate above 
baseline and burst activity of dopaminergic neurons (Foddai et al., 2004). With a number of 
these studies being done under anesthesia there is the possibility however, that anesthetic 
agents could disrupt normal neural activity and ultimately the effect of acute ethanol 
administration. 
 Our colleague at the University of Pennsylvania, Dr. William Doyon, aimed to better 
understand the motivational properties of ethanol by determining how ethanol modifies these 
neural circuits in freely moving animals. Evidence of discrete electrophysiological effects of 
ethanol on dopamine neurons compared with other VTA cell types, suggested a complex role 
of the VTA in alcohol-induced responses in freely moving animals (Doyon et al., 2020). The 
initial experiments were designed to assess the effect of a slow i.v. ethanol infusion on the 
firing activity of putative dopamine and GABA neurons, and unidentified neurons in vivo 
(Doyon et al., 2020). There was difficulty however, in knowing the time course of ethanol due 




experiments were conducted to overcome this limitation and to create a time course profile of 
ethanol in the VTA following an i.v. infusion. The analysis of dialysate and tissue 
concentrations were critical for final interpretations of how acute ethanol effects VTA neural 
activity. 
Methodology  
Male Long-Evans rats (300–450 g) were used for both in vivo recordings and 
microdialysis experiments. Multiple tetrode electrodes were used for in vivo recordings of the 
midbrain (VTA) and were conducted by Dr. Doyon. See Doyon et al. (2020) for 
electrophysiological effects of ethanol on the VTA.  
In vivo microdialysis and gas chromatography were used to quantify ethanol 
concentrations directly in the midbrain during and after the ethanol infusion (1.5 g/kg 
administered over 9 min). This approach allowed us to determine the rising and falling phase 
of ethanol over time. For the microdialysis experiments each animal was implanted with a 
microdialysis guide cannula aimed at the VTA, and an intravenous catheter was also surgically 
placed into the jugular vein. Surgeries and sample collection were conducted at the University 
of Pennsylvania (Doyon et al. 2020).  
Ethanol Analysis in Dialysates and Blood Samples 
Both dialysis and blood samples were shipped overnight from Philadelphia, PA to 
Austin, TX. Immediately after collection of each dialysis sample, 4 μl was transferred to a 0.5 
ml cryovial, and the vial was sealed (Sarstedt, Newton, NC, USA; part numbers 72.785 and 




solution and were transferred into a 2 ml glass vial and sealed. Two separate ethanol standards 
(40 mM) were included to be used as controls. Samples were shipped in a Styrofoam box with 
frozen cold packs to minimize loss of ethanol from the vials due to the volatile nature of 
ethanol. Once received, all samples were inspected for damage and transferred to a lab 
refrigerator. Dialysis samples were centrifuged at room temperature for 10 min at 5,000-10,000 
rpm. Then 2 μl of the sample were transferred to a 2 ml autosampler vial for analysis. 
Additionally, 50 ul of each blood sample were transferred into autosampler vials for further 
analysis. The 40 mM ethanol standards were used to quantitate the ethanol concentrations in 
the dialysis and blood samples.   
Ethanol concentrations in dialysates and blood were determined using gas 
chromatography  with flame ionization detection using methods modified from Carrillo et al. 
(2008). The gas chromatograph (Scion 436; Bruker, Netherlands) had a Bruker CP-8400 
autosampler attached for injections. Samples were heated for at least 45 min before analysis. 
The stationary phase was an HP Innowax capillary column (30 m x 0.53 mm x 1.0 um film 
thickness). CompassCDS (v. 3.0.0.68, Bruker, Netherlands) software was used to record and 
analyze all chromatograms.  
Results 
After each experiment animals were perfused and the brain was analyzed for probe 
placement in the midbrain. During the infusion of ethanol in the microdialysis experiment, we 
expected to see a linear increase in dialysate ethanol concentrations. A linear regression of 




the intravenous infusion of ethanol. Three out of four rats (n = 3) showed a significant 
correlation for linear regression (r = 0.98-0.99; p < 0.001). A fourth rat was excluded because 
the dialysate ethanol concentration did not follow a linear increase, which was reflected by a 
low r-value (0.02) that was not statistically significant (p = 0.97). It is possible that unknown 
damage occurred during the shipping process for the fourth rats’ dialysate samples. 
 During dialysate collection two-minute sampling intervals were used. We found that 
ethanol levels increased during ethanol infusion and peaked at the 10 minute mark (figure 5  ). 
 
 
Figure 5:  Time Course of Ethanol in Dialysate and Tissue. The graph shows the time 
course of ethanol over a sixty-minute time period in the VTA (n=3). Some error bars are 





  To estimate the brain ethanol levels blood samples were collected after dialysis from 
each rat (n=3) at 70 minutes after the i.v. ethanol infusion began. The ethanol concentrations 
in the blood were used to determine the in vivo extraction fraction for ethanol, with the 
assumption that blood and brain ethanol levels are equivalent at this time point. The peak 
ethanol levels in the midbrain were estimated to be 39 ± 3 mM at 10 minutes and declined to 
27 ± 3 mM at 60 minutes (figure 6)  
 
 
Figure 6: Dialysate, Tissue and Blood Ethanol Concentrations. The graph shows ethanol 
concentrations in dialysates and tissue at the end of the microdialysis collection (sixty 
minutes). As well, ethanol concentrations in blood samples are indicated after 
microdialysis collection at seventy minutes (n=3). (error bars represent the standard error 






 Published literature in the field has examined regional distribution of ethanol 
throughout the brain. Erickson (1976) used intracerebral perfusion cannulae to measure ethanol 
in several brain regions of freely moving rats. This study was the first to show that there is a 
significant differential distribution of ethanol in the rat brain after a 1 g/kg dose of ethanol, and 
that this unequal brain ethanol distribution may influence the behavioral effects of the drug. 
Although this study was able to distinguish differences in brain regions, he did not examine 
the VTA. This study made advancements in methodology on how we can measure ethanol in 
given brain region, specifically a time course was able to be determined in a given brain region 
in each animal. Tissue extraction experiments are also common throughout the field, however, 
are not the best method when creating a time course because multiple animals need to be used 
for each time point. This method is not only labor intensive but requires many animals. 
Microdialysis allows us the ability to collect serial samples from an animal and can be used to 
conduct a dynamic study on ethanol peak levels, as well as the decline of ethanol in brain 
regions over a given period. Past studies in our lab have successfully used this methodology to 
create a time course of ethanol in the striatum and the nucleus accumbens (Gonzales et al., 
1998, Howard et al., 2008). By utilizing this method when looking at the VTA we are able to 
understand the relationship between the pharmacological and behavioral effects of ethanol 
reaching the brain during and after exposure. In addition, knowing the time course can provide 
additional insight of neurobiological mechanisms of ethanol that might occur during that time 




Using this methodology we have now, for the first time, shown how ethanol 
concentrations change within the VTA during and after intravenous administration. The 
collection and analysis of dialysates were crucial for final interpretation of how acute ethanol 
affects VTA neural activity in our colleague’s in vivo tetrode experiments. Independently, our 
analysis was novel to the field in its ability to create a time course of ethanol in the VTA, 
showing peak levels of ethanol to be at ten minutes and declining over the course of sixty 
minutes. This is an important advance for the field that could aid in future interpretations in 
experiments exploring ethanol effects in the midbrain. In general, our method in microdialysis 
collection and analysis could also be used to quantitate ethanol in other brain regions. One 
advantage of using microdialysis for ethanol collection is that the probes are versatile and can 
be aimed or modified for specific brain regions. Being able to quantify ethanol allows for a 
greater understanding of how long ethanol is present and what concentrations can potentially 














As stated throughout the thesis individuals with AUD continue to suffer from a 
disruption of several neural systems underlying motivation, emotion, and cognition. AUD 
patients exhibit not only elevated motivation for alcohol but heightened stress and anxiety 
(Morrow and Creese 1986; Vazey et al., 2018). The high prevalence of AUD, alongside the 
wide range of effects of ethanol on biological, physiological, and neural functions continues to 
push the need for alcohol research. AUD research has aimed to not only better understand site-
specific actions of ethanol on several brain regions, but to also create treatments that can 
alleviate the multitude of symptoms that come along with AUD. The goal of my thesis was to 
be able to add to the field by providing novel techniques and information that can aid alcohol 
dependence research.  
In the first chapter the data collected from our ethanol vapor study showed that we were 
able to successfully induce alcohol dependence and withdrawal through a short ten-day vapor 
exposure. We were able to maintain all ethanol exposed Long Evans rats intoxicated 
throughout the ten days at a target BAC of at least 0.15 g/dl. In addition, all ethanol exposed 
rats showed signs of moderate withdrawal at four and eight hours after the chambers were 
turned off, with no signs of seizures. Through our data we demonstrate how important it is to 
consider individual differences in each animal that could potentially affect how severely 
intoxicated they become during each exposure. For example, severe intoxication could 
ultimately lead to weight loss during the experiment. This vapor study is currently the shortest 
vapor exposure model that has been able to successfully induce alcohol dependence over ten 
days in adult rats. 
Lastly, in the final chapter I aided a colleague, Dr. William Doyon, by using gas 




an i.v. ethanol infusion. Our analysis was novel to the field in its ability to create a time course 
of ethanol in the VTA, showing peak levels of ethanol to be at ten minutes and declining over 
the course of sixty minutes. In general, our method in microdialysis collection, analysis and 
use of an extraction fraction could also be used to quantitate ethanol in other brain regions. 
Being able to successfully quantify ethanol in other brain regions will allow for a greater 
understanding of how long ethanol is present and what concentrations can potentially affect 
neuronal networks. 
 Data collected from all these two chapters independently bring novel findings to the 
field that could strengthen techniques used in future alcohol dependence studies, as well as 
aiding in a better interpretation of the data. Our lab aims to continue to research alcohol 
dependance and withdrawal with the goal to examine possible neuromodulator targets that 
could be used as possible treatments for AUD in the future. 
It is well known that AUD affects a significant proportion of the population, and the 
make up of the individuals spans all demographic categories, and therefore it is not surprising 
that there are individual differences in susceptibility and symptoms of AUD that are expressed. 
One of the goals of research is to gain an understanding of all the individual mechanistic 
functions of neurotransmitters, and how those influence the synaptic networks throughout the 
brain. The results of this research should provide advancements that are able to lead to 
manageable treatments for individuals suffering from addiction. Whether an individual is more 
susceptible to the reward, withdrawal or is suffering from an existing disorder, such as anxiety, 
treatment will ultimately end up working for one group and not for another.  The results from 
this thesis have provided some new insight into factors that influence ethanol related behaviors 






Appendix: Possible Effects of Surgery on the Estrous Cycle 
The following appendix aims to explore additional work done throughout my master’s 
degree. It is important to state that additional studies would be needed to make a conclusion 
about the effects of surgery on the estrous cycle. 
The short length of the estrous cycle of rats makes them ideal for investigating changes 
occurring during the reproductive cycle. The estrous cycle lasts four/five days and is 
characterized as: proestrus, estrus, metestrus and diestrus, which can be determined according 
to the cell types observed in the vaginal smear (Marcondes et al., 2001). Ovarian hormone 
fluctuations have been known to lead to several behavioral changes in female rats. For example, 
early studies have reported changes in activity in behavioral paradigms such as the novel open-
field arena, as well as decreased locomotion, during different phases of the estrous cycle; (Gray 
and Levine, 1964). In addition, there is evidence that environmental stimuli can also affect 
estrous cycling (Gray and Levine, 1964). The importance of the estrous cycle has led to an 
increased interest in the possibility that the stages of the cycle can contribute to differences 
between males and females in various physiological measures. This interest has ultimately led 
to the more common practice of including female rats in an experiment. However, there is still 
concern of other possible variables such as stress from surgery that could affect the 
reproductive cycle of female animals and the consequent data collected.  
Our lab aims to examine the effects of ethanol on neurochemical components of the 




cycle, it is not known if ovarian hormone fluctuations would affect neurochemical 
concentrations. The following study was conducted to examine the effects of a common 
cannulation surgery done in our lab and how it could potentially affect female rodents before 
conducting a microdialysis experiment. 
Methodology 
Surgery 
Cannulation was carried out according to Duvauchelle et al. (1998) and Howard et al. 
(2008). Rats were initially anesthetized with 5% isoflurane in an induction chamber. Once the 
rat lost hind limb reflex, the isoflurane anesthetization was continued via a nose cone and 
lowered to 2.5% or a concentration low enough to keep the rat properly anesthetized. Rats were 
placed into a stereotaxic apparatus to implant the microdialysis cannula (21 gauge, 8 mm below 
the pedestal, Plastics One, Roanoke, VA). The skull was leveled, and a small hole was drilled 
above the brain region of interest (These females were involved in a pilot microdialysis 
experiment in our lab. Surgery was done by post-doctoral fellow Dr. Saul Jaime.). The guide 
cannula was secured onto the skull along with anchor screws with dental cement. An obturator 
was placed into the guide cannula to prevent entry of foreign matter into the cannula. The 
health status of each rat was monitored every day, and they were given a week for postsurgical 
recovery before any further experimentation or handling was conducted. 
Lavage 
 The assessment of changes in vaginal epithelial cells was used to track the estrous 




(except during the week of recovery from surgery). Female rats were covered and secured with 
a towel during the procedure to prevent any harm or excess stress. Daily samples were then 
taken with a 1 ul pipette between 10 am and 11 am. The pipette tip was inserted into the vaginal 
orifice and flushed with room temperature saline. The sample was then placed on a previously 
labeled designated slide for each individual female rat (slides: Fisherbrand Frosted Microscope 
Slides Precleaned, 12-550-343 (3” X 1” x 1.0mm)) for further cytological analysis. Once 
collection from all female rats was complete, each slide was examined with a microscope 
(Olympus Tokyo Ck) to characterize each vaginal smear. Goldman (2007) was consistently 
used to identify the stage of estrous cycle of each slide. Each vaginal smear was then left to 
dry overnight to be stored the next day in a microscope box for future hydration if necessary. 
Statistics 
Pre-surgical and post-surgical weights were analyzed using repeated measures of analysis of 
variance (ANOVA). Post hoc analyses (using Bonferroni corrections) were done to follow up 
on any significant findings from the ANOVA. For this experiment, significance was designated 




Lavages were performed on eight female Long Evans rats for five days before 
undergoing cannula surgery. Of those eight, five female rats were identified as cycling prior to 





Table 3: Estrous Cycle Before and After Cannula Surgery 
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Table 3 shows that all five female rats cycled through proestrus at least once before 
surgery. After cannula surgery and a week of recovery, we found that four of the female Long 
Evans rats continued to cycle normally, while the fifth (SJF15) stopped cycling and remained 
in the metestrus/diestrus stage. 
Weight Loss 
 Weights for each female rat were collected before and after cannula surgery. Notably, 
all five female Long Evans rats began to lose weight after surgery. Figure 7 shows the average 
daily weights pre-surgery and post-surgery. A repeated one-way ANOVA was conducted on 
all daily averages and showed that there was a difference in weights throughout the experiment. 
(F (12,48) = 3.264, p < 0.05). However, further post hoc analyses did not result in a significant 
difference in pre-surgery weights when compared to each post-surgery weight. Even though 
we did find an overall significant difference in weights, more in-depth post hoc analyses would 
be necessary to find the source.  It is possible that the female rats experienced weight loss due 
to surgery but had already begun to recover the weight back during their recovery period. 










 It is important to state that more data needs to be collected to make a definite conclusion 
on the effects of surgery on the estrous cycle. The data from the present pilot shows that all 
five female Long Evans rats were cycling prior to cannula surgery. After surgery and a week 
of recovery, we found that four animals continued to cycle while one remained in the 
diestrus/metestrus stage. Additionally, there was a significant difference in pre- and post-
surgery weights. However, we were not able to identify the cause of this difference with the 
Figure 7: Female Weights Pre and Post Surgery. The following graph shows 
female (n=5) weights in grams pre-surgery and post-surgery. A difference in 




post hoc tests used in this study to compare individual pre- and post-surgery weights. Our data 
points to the possibility that the cannula surgery was severe enough to cause weight loss in the 
beginning of the recovery period, but that the rats began to gain it back towards the end of 
recovery. As such, it is less likely that the initial post-surgery weight loss was the cause for 
only one rat to stop cycling. 
 Stress caused by cannula surgery is more than likely the cause that halted estrous 
cycling in that individual rat. Silva (2020) used guide cannulae for microinjections in female 
Rattus norvegicus and found that only seven out of thirty females continued to cycle one day 
after surgery. Additionally, twenty-one rats needed up to sixteen days to cycle again, while the 
remaining two rats were unable to cycle and therefore taken out of the study. Robinson (2002) 
was also able to successfully examine the effects of gender and estrous cycle on the 
pharmacokinetics of ethanol through microdialysis by allowing females rats an appropriate 
time to recover from the surgery. Our data is consistent with the previous findings showing 
that invasive surgical procedures can cause transient effects in female rats. More work is 
necessary to explore the possible effects of surgery on the estrous cycle, however it is suggested 
that future studies should consider monitoring rodents before an experimental treatment for at 
least two cycles to better confirm that rats are cycling. In addition, female rats should be given 
proper recovery time, from one to two weeks, which would not only allow any weight loss to 








Aghajanian, G. K., and C. P. Vandermaelen. 1982. 'Intracellular identification of 
central noradrenergic and serotonergic neurons by a new double labeling 
procedure', J Neurosci, 2: 1786-92. 
Bangasser, D. A., and R. J. Valentino. 2014. 'Sex differences in stress-related 
psychiatric disorders: neurobiological perspectives', Front 
Neuroendocrinol, 35: 303-19. 
Becker, J. B., and G. F. Koob. 2016. 'Sex Differences in Animal Models: Focus 
on Addiction', Pharmacol Rev, 68: 242-63. 
Borg, S., H. Kvande, and G. Sedvall. 1981. 'Central norepinephrine metabolism 
during alcohol intoxication in addicts and healthy volunteers', Science, 
213: 1135-7. 
Caine, S. B., C. A. Bowen, G. Yu, D. Zuzga, S. S. Negus, and N. K. Mello. 2004. 
'Effect of gonadectomy and gonadal hormone replacement on cocaine 
self-administration in female and male rats', Neuropsychopharmacology, 
29: 929-42. 
Carrillo, J., E. C. Howard, M. Moten, B. D. Houck, C. L. Czachowski, and R. A. 
Gonzales. 2008. 'A 3-day exposure to 10% ethanol with 10% sucrose 
successfully initiates ethanol self-administration', Alcohol, 42: 171-8. 
Deehan, G. A., Jr., E. A. Engleman, Z. M. Ding, W. J. McBride, and Z. A. Rodd. 
2013. 'Microinjections of acetaldehyde or salsolinol into the posterior 
ventral tegmental area increase dopamine release in the nucleus 




Deehan, G. A., Jr., S. R. Hauser, J. A. Wilden, W. A. Truitt, and Z. A. Rodd. 
2013. 'Elucidating the biological basis for the reinforcing actions of 
alcohol in the mesolimbic dopamine system: the role of active metabolites 
of alcohol', Front Behav Neurosci, 7: 104. 
Doyon, W. M., A. Ostroumov, T. Ontiveros, R. A. Gonzales, and J. A. Dani. 
2021. 'Ethanol produces multiple electrophysiological effects on ventral 
tegmental area neurons in freely moving rats', Addict Biol, 26: e12899. 
Duvauchelle, C. L., S. M. Fleming, and C. Kornetsky. 1998. 'Prefrontal cortex 
infusions of SCH 23390 cause immediate and delayed effects on ventral 
tegmental area stimulation reward', Brain Res, 811: 57-62. 
Erickson, C. K. (1976). Regional distribution of ethanol in rat brain. Life 
Sciences,19(9),1439–1446.https://doi.org/10.1016/0024-3205(76)90446-
x  
Eskinder, H., C. J. Hillard, R. A. Wilke, and G. J. Gross. 1989. 'Effect of KT-
362, a putative intracellular calcium antagonist, on norepinephrine-
induced contractions and inositol monophosphate accumulation in canine 
femoral artery', J Cardiovasc Pharmacol, 13: 502-7. 
Evans, S. M., and R. W. Foltin. 2006. 'Pharmacokinetics of repeated doses of 
intravenous cocaine across the menstrual cycle in rhesus monkeys', 
Pharmacol Biochem Behav, 83: 56-66. 
Foddai, M., G. Dosia, S. Spiga, and M. Diana. 2004. 'Acetaldehyde increases 





Fredriksson, I., N. Jayaram-Lindstrom, M. Wirf, E. Nylander, E. Nystrom, K. 
Jardemark, and P. Steensland. 2015. 'Evaluation of guanfacine as a 
potential medication for alcohol use disorder in long-term drinking rats: 
behavioral and electrophysiological findings', 
Neuropsychopharmacology, 40: 1130-40. 
Funk, C. K., L. E. O'Dell, E. F. Crawford, and G. F. Koob. 2006. 'Corticotropin-
releasing factor within the central nucleus of the amygdala mediates 
enhanced ethanol self-administration in withdrawn, ethanol-dependent 
rats', J Neurosci, 26: 11324-32. 
Funk, C. K., E. P. Zorrilla, M. J. Lee, K. C. Rice, and G. F. Koob. 2007. 
'Corticotropin-releasing factor 1 antagonists selectively reduce ethanol 
self-administration in ethanol-dependent rats', Biol Psychiatry, 61: 78-86. 
Gilpin, N. W., and G. F. Koob. 2010. 'Effects of beta-adrenoceptor antagonists 
on alcohol drinking by alcohol-dependent rats', Psychopharmacology 
(Berl), 212: 431-9. 
Gilpin, N. W., A. D. Smith, M. Cole, F. Weiss, G. F. Koob, and H. N. 
Richardson. 2009. 'Operant behavior and alcohol levels in blood and brain 
of alcohol-dependent rats', Alcohol Clin Exp Res, 33: 2113-23. 
Goldman, J. M., A. S. Murr, and R. L. Cooper. 2007. 'The rodent estrous cycle: 
characterization of vaginal cytology and its utility in toxicological studies', 
Birth Defects Res B Dev Reprod Toxicol, 80: 84-97. 
Gonzales, R. A., McNabb, J. C., Yim, H. J., Ripley, T., &amp; Bungay, P. M. 




Clinical and Experimental Research, 22(4), 858–867. 
https://doi.org/10.1111/j.1530-0277.1998.tb03880.x 
Gray, J. A., and S. Levine. 1964. 'Effect of Induced Cestrus on Emotional 
Behaviour in Selected Strains of Rats', Nature, 201: 1198-200. 
Haass-Koffler, C. L., R. M. Swift, and L. Leggio. 2018. 'Noradrenergic targets 
for the treatment of alcohol use disorder', Psychopharmacology (Berl), 
235: 1625-34. 
Healey, K. L., S. Kibble, A. Bell, S. Hodges, and H. S. Swartzwelder. 2020. 
'Effects of adolescent intermittent ethanol on hippocampal expression of 
glutamate homeostasis and astrocyte-neuronal tethering proteins in male 
and female rats', J Neurosci Res. 
Howard, E. C., C. J. Schier, J. S. Wetzel, C. L. Duvauchelle, and R. A. Gonzales. 
2008. 'The shell of the nucleus accumbens has a higher dopamine response 
compared with the core after non-contingent intravenous ethanol 
administration', Neuroscience, 154: 1042-53. 
Howes, L. G., and J. L. Reid. 1985. 'Decreased vascular responsiveness to 
noradrenaline following regular ethanol consumption', Br J Clin 
Pharmacol, 20: 669-74. 
Jaime, S., Vena, A., &amp; Gonzales, R. A. (2017). Microdialysis of 
norepinephrine in prefrontal cortex and ventral striatum and effects of 
ethanol in the long EVANS rat. Alcohol, 60, 239. 
https://doi.org/10.1016/j.alcohol.2017.02.338 
Jaime, S., A. A. Vena, and R. A. Gonzales. 2020. 'Intravenous Ethanol 




Norepinephrine Concentration in the Mesocorticolimbic Systems of Male 
Long Evans Rats', Alcohol Clin Exp Res, 44: 1529-39. 
Karoum, F., N. H. Neff, and R. J. Wyatt. 1976. 'Distribution and turnover rate of 
vanillylmandelic acid and 3-methoxy-4-hydroxyphenylglycol in rat brain', 
J Neurochem, 27: 33-5. 
Keyes, K. M., B. F. Grant, and D. S. Hasin. 2008. 'Evidence for a closing gender 
gap in alcohol use, abuse, and dependence in the United States population', 
Drug Alcohol Depend, 93: 21-9. 
Kushner, M. G., K. Abrams, P. Thuras, P. Thuras, and K. L. Hanson. 2000. 
'Individual differences predictive of drinking to manage anxiety among 
non-problem drinkers with panic disorder', Alcohol Clin Exp Res, 24: 
448-58. 
Lacy, R. T., J. C. Strickland, M. A. Feinstein, A. M. Robinson, and M. A. Smith. 
2016. 'The effects of sex, estrous cycle, and social contact on cocaine and 
heroin self-administration in rats', Psychopharmacology (Berl), 233: 
3201-10. 
Lanteri, C., L. Salomon, Y. Torrens, J. Glowinski, and J. P. Tassin. 2008. 'Drugs 
of abuse specifically sensitize noradrenergic and serotonergic neurons via 
a non-dopaminergic mechanism', Neuropsychopharmacology, 33: 1724-
34. 
Le, A. D., S. Harding, W. Juzytsch, D. Funk, and Y. Shaham. 2005. 'Role of 
alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking 





Li, T. K., and L. Lumeng. 1984. 'Alcohol preference and voluntary alcohol 
intakes of inbred rat strains and the National Institutes of Health 
heterogeneous stock of rats', Alcohol Clin Exp Res, 8: 485-6. 
Majchrowicz, E. 1975. 'Induction of physical dependence upon ethanol and the 
associated behavioral changes in rats', Psychopharmacologia, 43: 245-54. 
Marcondes, F. K., K. J. Miguel, L. L. Melo, and R. C. Spadari-Bratfisch. 2001. 
'Estrous cycle influences the response of female rats in the elevated plus-
maze test', Physiol Behav, 74: 435-40. 
Meliska, C. J., A. Bartke, G. McGlacken, and R. A. Jensen. 1995. 'Ethanol, 
nicotine, amphetamine, and aspartame consumption and preferences in 
C57BL/6 and DBA/2 mice', Pharmacol Biochem Behav, 50: 619-26. 
Michel, A. D., D. N. Loury, and R. L. Whiting. 1989. 'Identification of a single 
alpha 1-adrenoceptor corresponding to the alpha 1A-subtype in rat 
submaxillary gland', Br J Pharmacol, 98: 883-9. 
Mirijello, A., C. D'Angelo, A. Ferrulli, G. Vassallo, M. Antonelli, F. Caputo, L. 
Leggio, A. Gasbarrini, and G. Addolorato. 2015. 'Identification and 
management of alcohol withdrawal syndrome', Drugs, 75: 353-65. 
Morrow, A. L., A. D. Chen, and I. Creese. 1986. 'Modulation of alpha-1 
adrenergic receptors in rat brain following chronic reserpine', Neurochem 
Int, 8: 243-7. 
Morrow, A. L., and I. Creese. 1986. 'Characterization of alpha 1-adrenergic 
receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and 




Nair-Roberts, R. G., S. D. Chatelain-Badie, E. Benson, H. White-Cooper, J. P. 
Bolam, and M. A. Ungless. 2008. 'Stereological estimates of 
dopaminergic, GABAergic and glutamatergic neurons in the ventral 
tegmental area, substantia nigra and retrorubral field in the rat', 
Neuroscience, 152: 1024-31. 
NIAAA. (2021). Alcohol use disorder. National Institute on Alcohol Abuse and 
Alcoholism. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-
use-disorder. 
O'Dell, L. E., A. J. Roberts, R. T. Smith, and G. F. Koob. 2004. 'Enhanced 
alcohol self-administration after intermittent versus continuous alcohol 
vapor exposure', Alcohol Clin Exp Res, 28: 1676-82. 
Petrakis, I. L., N. Desai, R. Gueorguieva, A. Arias, E. O'Brien, J. S. Jane, K. 
Sevarino, S. Southwick, and E. Ralevski. 2016. 'Prazosin for Veterans 
with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: 
A Clinical Trial', Alcohol Clin Exp Res, 40: 178-86. 
Rasmussen, D. D., L. Alexander, J. Malone, D. Federoff, and J. C. Froehlich. 
2014. 'The alpha2-adrenergic receptor agonist, clonidine, reduces alcohol 
drinking in alcohol-preferring (P) rats', Alcohol, 48: 543-9. 
Rasmussen, D. D., L. L. Alexander, M. A. Raskind, and J. C. Froehlich. 2009. 
'The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol 
drinking in alcohol-preferring (P) rats', Alcohol Clin Exp Res, 33: 264-72. 
Retson, T. A., B. A. Reyes, and E. J. Van Bockstaele. 2015. 'Chronic alcohol 




neurons and the subcellular distribution of corticotropin releasing factor 
receptors', Prog Neuropsychopharmacol Biol Psychiatry, 56: 66-74. 
Rimondini, R., W. Sommer, and M. Heilig. 2003. 'A temporal threshold for 
induction of persistent alcohol preference: behavioral evidence in a rat 
model of intermittent intoxication', J Stud Alcohol, 64: 445-9. 
Robinson, D. L., L. J. Brunner, and R. A. Gonzales. 2002. 'Effect of gender and 
estrous cycle on the pharmacokinetics of ethanol in the rat brain', Alcohol 
Clin Exp Res, 26: 165-72. 
Robinson, D. L., J. A. Lara, L. J. Brunner, and R. A. Gonzales. 2000. 
'Quantification of ethanol concentrations in the extracellular fluid of the 
rat brain: in vivo calibration of microdialysis probes', J Neurochem, 75: 
1685-93. 
Ryabinin, A. E., J. R. Criado, S. J. Henriksen, F. E. Bloom, and M. C. Wilson. 
1997. 'Differential sensitivity of c-Fos expression in hippocampus and 
other brain regions to moderate and low doses of alcohol', Mol Psychiatry, 
2: 32-43. 
Silva, C. C., M. Bolanos-Hurtado, C. Juarez-Tapia, A. Flores, I. Arrieta-Cruz, 
M. E. Cruz, and R. Dominguez. 2020. 'Unraveling the Role of Discrete 
Areas of the Rat Brain in the Regulation of Ovulation through Reversible 
Inactivation by Tetrodotoxin Microinjections', J Vis Exp. 
Simpson, T. L., A. J. Saxon, C. W. Meredith, C. A. Malte, B. McBride, L. C. 
Ferguson, C. A. Gross, K. L. Hart, and M. Raskind. 2009. 'A pilot trial of 
the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence', 




Skelly, M. J., and J. L. Weiner. 2014. 'Chronic treatment with prazosin or 
duloxetine lessens concurrent anxiety-like behavior and alcohol intake: 
evidence of disrupted noradrenergic signaling in anxiety-related alcohol 
use', Brain Behav, 4: 468-83. 
Trantham-Davidson, H., S. W. Centanni, S. C. Garr, N. N. New, P. J. 
Mulholland, J. T. Gass, E. J. Glover, S. B. Floresco, F. T. Crews, H. R. 
Krishnan, S. C. Pandey, and L. J. Chandler. 2017. 'Binge-Like Alcohol 
Exposure During Adolescence Disrupts Dopaminergic Neurotransmission 
in the Adult Prelimbic Cortex', Neuropsychopharmacology, 42: 1024-36. 
Vazey, E. M., C. R. den Hartog, and D. E. Moorman. 2018. 'Central 
Noradrenergic Interactions with Alcohol and Regulation of Alcohol-
Related Behaviors', Handb Exp Pharmacol, 248: 239-60. 
Vazey, E. M., D. E. Moorman, and G. Aston-Jones. 2018. 'Phasic locus coeruleus 
activity regulates cortical encoding of salience information', Proc Natl 
Acad Sci U S A, 115: E9439-E48. 
Vena, A. A., S. L. Zandy, R. U. Cofresi, and R. A. Gonzales. 2020. 'Behavioral, 
neurobiological, and neurochemical mechanisms of ethanol self-
administration: A translational review', Pharmacol Ther, 212: 107573. 
Ventura, R., D. De Carolis, A. Alcaro, and S. Puglisi-Allegra. 2006. 'Ethanol 
consumption and reward depend on norepinephrine in the prefrontal 
cortex', Neuroreport, 17: 1813-7. 
Ventura, R., E. C. Latagliata, C. Morrone, I. La Mela, and S. Puglisi-Allegra. 
2008. 'Prefrontal norepinephrine determines attribution of "high" 




Vilpoux, C., V. Warnault, O. Pierrefiche, M. Daoust, and M. Naassila. 2009. 
'Ethanol-sensitive brain regions in rat and mouse: a cartographic review, 
using immediate early gene expression', Alcohol Clin Exp Res, 33: 945-
69. 
Walker, B. M., D. D. Rasmussen, M. A. Raskind, and G. F. Koob. 2008. 'alpha1-
noradrenergic receptor antagonism blocks dependence-induced increases 
in responding for ethanol', Alcohol, 42: 91-7. 
Weinshenker, D., N. C. Rust, N. S. Miller, and R. D. Palmiter. 2000. 'Ethanol-
associated behaviors of mice lacking norepinephrine', J Neurosci, 20: 
3157-64.  
 
 
